Welcome to BioSeeker Group!

Analytical Tool - Breast Cancer

Additional Information

Published Date Feb 21, 2012
Format PDF & Software Application
Publisher BioSeeker Group

Availability: In stock

€3,100.00

Quick Overview

The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development.
Request free sample pages from Analytical Tool - Breast Cancer

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in breast cancer R&D
  • Information on key industry related breast cancer projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of breast cancer therapeutics
  • Identifying emerging breast cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of breast cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Request free sample pages from Analytical Tool - Breast Cancer

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Angiogenesis in Oncology
The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More


Analytical Tool - Lung Cancer
Understand the clinical and strategic challenges towards the commercialization of drugs in lung cancer treatments. Learn More

Other selected research from the 'R&D' category:


HCV R&D and Business Development Database
This CD-ROM product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. Learn More


IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 187 companies plus partners who are today developing 245 IL-2 pathway targeting drugs in 698 developmental projects in cancer across 127 different targets. In addition, there are 4 suspended drugs and another 104 drugs where development has been ceased. Learn More

Other selected research from the 'Oncology' category:


Renal Cancer Drug Pipeline Update 2012
BioSeeker Group have identified 159 companies plus partners who are today developing 192 drugs targeting renal cancer in development. across 169 different targets. In addition, there are 4 suspended drugs and another 59 drugs where development has been ceased. Learn More


Triple Analysis: Breast Cancer, Apoptosis and Cancer Vaccines
This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More